We are live on ! Find out more
ANEB

Anebulo Pharmaceuticals
ANEB

Delisted

ANEB was delisted on the 27th of February, 2026.

Back to rankings

9 hedge funds and large institutions have $28.7M invested in Anebulo Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

17.99% more ownership

Funds ownership: 0% → 17.99% (+18%)

Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
2L
22NW LP
Washington
+$24.9M
2
MP
Mangrove Partners
Connecticut
+$3.19M
3
LCM
Laurion Capital Management
New York
+$1.67M
4
IC
Ikarian Capital
Texas
+$1.3M
5
BFM
Boothbay Fund Management
New York
+$148K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
2L
1
22NW LP
Washington
$22.8M +$24.9M +3,343,565 New
MP
2
Mangrove Partners
Connecticut
$2.92M +$3.19M +428,500 New
LCM
3
Laurion Capital Management
New York
$1.55M +$1.67M +225,000 New
IC
4
Ikarian Capital
Texas
$1.2M +$1.3M +174,811 New
BFM
5
Boothbay Fund Management
New York
$135K +$148K +19,835 New
BlackRock
6
BlackRock
New York
$53K +$57.8K +7,773 New
UBS Group
7
UBS Group
Switzerland
$2K +$1.74K +234 New
TRCT
8
Tower Research Capital (TRC)
New York
$1K +$1.18K +158 New
Wells Fargo
9
Wells Fargo
California
– +$141 +19 New

ANEB Hedge Fund Activity: Q2 2021 in Review

9 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Anebulo Pharmaceuticals (ANEB) for Q2 2021, worth a combined $28.7M.

Buyers outnumbered sellers: 9 funds opened new ANEB positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was 22NW LP, opening a new position worth an estimated $24.9M.

  • 9 institutional investors held Anebulo Pharmaceuticals (ANEB) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $28.7M of Anebulo Pharmaceuticals stock for Q2 2021.
  • 9 funds opened new Anebulo Pharmaceuticals positions in Q2 2021 and 0 closed out, a net change of +9 holders.
  • The largest Anebulo Pharmaceuticals buyer in Q2 2021 was 22NW LP, an estimated $24.9M added.

Based on aggregated 13F filings for Q2 2021.